IMMUNITYBIO, INC. (IBRX)

Clinical trial NCT07556757 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2028-12-01 → 2026-07-01 3. primary completion date: 2028-12-01 → 2026-07-01 4. enrollment: 10 → 4 participants 5. enrollment type: ESTIMATED → ACTUAL